herceptin Archives -

Roche’s Herceptin/Perjeta combo product nears EU approval

Phil Taylor CHMP, herceptin, Perjeta, Phesgo, Roche, Xofluza 0 Comment

The EMA’s human medicines committee has recommended approval of a fixed-dose combination of Roche’s breast cancer drugs Herceptin

Roche’s Herceptin/Perjeta combo product nears EU approval

https://pharmaphorum.com/news/roches-herceptin-perjeta-combo-product-nears-eu-approval/

News/ News/ Sales and Marketing/ Top stories

Amgen’s cancer biosimilars stay on US market as court battle with Roche ends

Richard Staines Amgen, Avastin, biosimilars, cancer, Genentech, herceptin, litigation, patent, Roche 0 Comment

Amgen has scored yet another home run in the US courts, this time seeing off a legal challenge

Amgen’s cancer biosimilars stay on US market as court battle with Roche ends

https://pharmaphorum.com/news/amgens-cancer-biosimilars-stay-on-us-market-as-court-battle-with-roche-ends/

News/ News/ Sales and Marketing

Roche raises 2019 outlook, shrugging off biosimilar threat

Phil Taylor Avastin, biosimilar, Hemlibra, herceptin, Ocrevus, Rituxan, Roche, Tecentriq 0 Comment

New product sales helped Roche to a healthy 9% increase in sales in the first half of the

Roche raises 2019 outlook, shrugging off biosimilar threat

https://pharmaphorum.com/news/roche-raises-2019-outlook-shrugging-off-biosimilar-threat/

News/ News

New deals extend Mundipharma biosimilar reach

Phil Taylor biosimilar, herceptin, Mundipharma, Roche 0 Comment

Mundipharma has fleshed out its range of biosimilars by acquiring Tuznue, a version of Roche’s breast cancer blockbuster

New deals extend Mundipharma biosimilar reach

https://pharmaphorum.com/news-market-access/new-deals-extend-mundipharma-biosimilar-reach/

Market Access/ News/ News/ News/ Oncology

Roche seeks Kadcyla boost to fend off Herceptin biosimilars

George Underwood breast cancer, herceptin, Kadclya, Roche 0 Comment

As biosimilar competition to Herceptin ramps up, Roche is looking to bolster its position in HER2-positive breast cancer

Roche seeks Kadcyla boost to fend off Herceptin biosimilars

https://pharmaphorum.com/news/roche-seeks-new-kadcyla-indication/

Market Access/ News/ News/ News/ Oncology

Pfizer wins Herceptin biosimilar approval in Europe

Piotr Wnuk biosimilar, breast cancer, European Commission, HER2-positive breast cancer, herceptin, Oncology, Pfizer, Trazimera 0 Comment

European Commission (EC) has approved Pfizer’s Trazimera, for breast and gastric cancer treatment, marking it as pharma’s first

Pfizer wins Herceptin biosimilar approval in Europe

https://pharmaphorum.com/news/herceptin-biosimilar-european-approval/

Cancer/ Healthcare/ News/ UK & Europe

MSD launches first Herceptin biosimilar in UK

Andrew McConaghie biosimilars, herceptin 0 Comment

Ontruzant, the first biosimilar version of Roche’s Herceptin (trastuzumab) in Europe has been launched in the UK by MSD.

MSD launches first Herceptin biosimilar in UK

https://pharmaphorum.com/news/msd-launches-first-herceptin-biosimilar-in-uk/

Healthcare/ News/ News/ Oncology/ Pharma Market Access/ UK & Europe

Its Herceptin biosimilar nearing launch, Celltrion begins work on Keytruda copy

Andrew McConaghie biosimilars, Celltrion, herceptin, Keytruda, Roche 0 Comment

South Korea’s Celltrion has started work on a biosimilar version of pembrolizumab, Merck & Co’s blockbuster immunotherapy Keytruda.

Its Herceptin biosimilar nearing launch, Celltrion begins work on Keytruda copy

https://pharmaphorum.com/news/herceptin-biosimilar-nearing-launch-celltrion-begins-work-keytruda-copy/

News/ R&D

Samsung Bioepis files Herceptin biosimilar in EU

Richard Staines biosimilars, ema, herceptin, Roche, Samsung Bioepis 0 Comment

South Korean firm trying to copy breast cancer blockbuster.

Samsung Bioepis files Herceptin biosimilar in EU

https://pharmaphorum.com/news/samsung-bioepis-files-herceptin-biosimilar-eu/

Trending

herceptin

Login